Phytoalexin resveratrol (3-4'-5-trihydroxystilbene) modulates granulocyte and monocyte endothelial adhesion.
Ferrero
M E
ME
Institute of General Pathology, Medical Faculty, University of Milan, Italy.
Bertelli
A A
AA
Pellegatta
F
F
Fulgenzi
A
A
Corsi
M M
MM
Bertelli
A
A
D000911:Antibodies, Monoclonal / Q000494:pharmacology; D002448:Cell Adhesion / Q000187:drug effects* / Q000502:physiology; D002460:Cell Line; D004730:Endothelium, Vascular / Q000187:drug effects / Q000502:physiology*; D006098:Granulocytes / Q000187:drug effects / Q000502:physiology*; D006801:Humans; D009000:Monocytes / Q000187:drug effects / Q000502:physiology*; D010975:Platelet Aggregation Inhibitors / Q000494:pharmacology*; D000077185:Resveratrol; D012501:Saphenous Vein; D013267:Stilbenes / Q000494:pharmacology*; D020298:U937 Cells; D019010:Vascular Cell Adhesion Molecule-1 / Q000276:immunology / Q000502:physiology
D000911:Antibodies, Monoclonal; D010975:Platelet Aggregation Inhibitors; D013267:Stilbenes; D019010:Vascular Cell Adhesion Molecule-1; D000077185:Resveratrol